Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Hepatology. 2022 Apr 7;75(6):1604–1626. doi: 10.1002/hep.32447

Figure 2. Potential combination strategies employing ICI in HCC.

Figure 2.

Multiple therapies under investigation have the potential to enhance the anti-tumor response in HCC when combined with ICI. These include combination of ICI with other immunotherapeutics such as adoptive cell therapies, vaccines, and oncolytic viruses. ICI can also be combined with systemic therapies and locoregional therapies. ICI, immune checkpoint inhibition.